Actively Recruiting
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
Led by Rui Yang · Updated on 2024-11-14
260
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A single-center, prospective, randomised controlled clinical trial (1:1 treatment ratio), designed to investigate the efficacy and safety of autologous SVF in improving the pregnancy outcome of infertile patients with POI.
CONDITIONS
Official Title
Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 20 to 39 years who want to have children
- Cessation of menstruation or infrequent menstruation for at least 4 months
- Basal follicle stimulating hormone (FSH) level over 25 U/L on at least two tests taken 4 weeks apart
- Anti-Mullerian hormone (AMH) level 1.1 ng/ml or lower
- Women with a healthy uterus and both ovaries
- Voluntary participation with informed consent obtained
You will not qualify if you...
- Women with autoimmune diseases
- Women with abnormal or uncontrolled thyroid function
- Women with unclear benign or malignant tumors in both ovaries or fallopian tubes
- Women with a history of malignant tumors, radiation, or chemotherapy
- Women with venous thrombosis or pulmonary embolism during screening
- Women with severe illnesses affecting pregnancy suitability, including circulatory, urinary, digestive, endocrine, respiratory, immune, mental, or neurological disorders
- Women who used systemic glucocorticoids or immunosuppressants continuously for 3 or more weeks within 6 months before treatment, or high-dose glucocorticoids within 3 days before treatment
- Women allergic to ingredients of the study drugs
- Women with a family history of severe genetic diseases or gynecologic cancers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
R
Rui Yang, M.D.
CONTACT
Y
Yaodong Zhang, Bachelor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here